1. AHRO : Austin Health Research Online

Sze Ting Lee

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Sze Ting Lee
Full Name
Lee, Sze Ting
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Date Issued:  [2020 TO 2024]
Date Issued:  2021

Results 1-13 of 13 (Search time: 0.009 seconds).

Publication YearTitleAuthor(s)
120-Oct-2021Diagnosis, management and follow up of peripheral T cell lymphomas: A Consensus Practice Statement from the Australasian Lymphoma Alliance.Hapgood, G; Latimer, M; Lee, Sze Ting ; Kuss, B; Lade, S; Tobin, J W D; Purtill, D; Campbell, B A; Prince, H M; Hawkes, Eliza A ; Shortt, J; Radeski, D
216-Sep-2021Diffuse large B-cell lymphoma: A consensus practice statement from the Australasian Lymphoma Alliance.Wight, Joel C ; Hamad, N; Campbell, B A; Ku, M; Lee, K; Rose, H; Armytage, T; Latimer, M; Lee, H P; Lee, Sze Ting ; Dickinson, M; Khor, Richard ; Verner, E
33-Aug-2021Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin.Gan, Hui K ; Parakh, Sagun ; Lassman, Andrew B; Seow, Aidan; Lau, Eddie ; Lee, Sze Ting ; Ameratunga, Malaka; Perchyonok, Yuliya ; Cao, Diana; Burvenich, Ingrid J G; O'Keefe, Graeme J; Rigopoulos, Angela; Gomez, Erica; Maag, David; Scott, Andrew M 
48-Jul-2021Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma.Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey 
51-Jul-2021Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods.Ayati, Narjess ; Lee, Sze Ting ; Zakavi, S Rasoul; Cheng, Melissa; Lau, W F Eddie; Parakh, Sagun ; Pathmaraj, Kunthi ; Scott, Andrew M 
61-Jun-2021A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.Gan, Hui K ; Burge, Matthew; Solomon, Benjamin; Lee, Sze Ting ; Holen, Kyle D; Zhang, Yumin; Ciprotti, Marika; Lee, F T; Manusinghe, Wijth; Fischer, Judee; Ansell, Peter; Fox, Gerard; Xiong, Hao; Reilly, Edward B; Humerickhouse, Rod; Scott, Andrew M 
7May-2021Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.Lee, Sze Ting ; Muralidharan, Vijayaragavan ; Tebbutt, Niall C ; Wong, P; Fang, C; Liu, Z; Gan, Hui K ; Sachinidis, J; Pathmaraj, Kunthi ; Christophi, Christopher ; Scott, Andrew M 
817-Mar-2021Evaluation of 18F-FMISO PET and 18F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy.Lee, Sze Ting ; Tebbutt, Niall C ; Gan, Hui K ; Liu, Zhanqi; Sachinidis, John; Pathmaraj, Kunthi ; Scott, Andrew M 
9Mar-2021A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls.McMahon, James H; Zerbato, Jennifer M; Lau, Jillian S Y; Lange, Jaclyn L; Roche, Michael; Tumpach, Carolin; Dantanarayana, Ashanti; Rhodes, Ajantha; Chang, Judy; Rasmussen, Thomas A; Mackenzie, Charlene A; Alt, Karen; Hagenauer, Michelle; Roney, Janine; O'Bryan, Jessica; Carey, Alexandra; McIntyre, Richard; Beech, Paul; O'Keefe, Graeme J; Wichmann, Christian W; Scott, Fiona E; Guo, Nancy; Lee, Sze Ting ; Liu, Zhanqi; Caskey, Marina; Nussenzweig, Michel C; Donnelly, Paul S; Egan, Gary; Hagemeyer, Christoph E; Scott, Andrew M ; Lewin, Sharon R
10Mar-2021Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.Cutler, Cathy S; Bailey, Elizabeth; Kumar, Vijay; Schwarz, Sally W; Bom, Hee-Seung; Hatazawa, Jun; Paez, Diana; Orellana, Pilar; Louw, Lizette; Mut, Fernando; Kato, Hiroki; Chiti, Arturo; Frangos, Savvas; Fahey, Frederic; Dillehay, Gary; Oh, Seung J; Lee, Dong S; Lee, Sze Ting ; Nunez-Miller, Rodolfo; Bandhopadhyaya, Guru; Pradhan, Prasanta K; Scott, Andrew M 
1127-Feb-2021[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.Hofman, Michael S; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Joshua, Anthony M; Goh, Jeffrey C; Pattison, David A; Tan, Thean Hsiang; Kirkwood, Ian D; Ng, Siobhan; Francis, Roslyn J; Gedye, Craig; Rutherford, Natalie K; Weickhardt, Andrew J ; Scott, Andrew M ; Lee, Sze Ting ; Kwan, Edmond M; Azad, Arun A; Ramdave, Shakher; Redfern, Andrew D; Macdonald, William; Guminski, Alex; Hsiao, Edward; Chua, Wei; Lin, Peter; Zhang, Alison Y; McJannett, Margaret M; Stockler, Martin R; Violet, John A; Williams, Scott G; Martin, Andrew J; Davis, Ian D
12Feb-2021The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis.Ayati, Narjess ; Sadeghi, Ramin; Kiamanesh, Zahra; Lee, Sze Ting ; Zakavi, S Rasoul; Scott, Andrew M 
132021Acute graft-versus-host disease associated cerebellitis as the cause of pyrexia of unknown origin detected with 18F-FDG-PET/CT.Jewell, Kerry E; Kuzich, James A; Lee, Sze Ting ; Trethowan, Rebecca; Macdonell, Richard A L ; Schwarer, Anthony P